Main container

Post-Market, Non- Randomized, Multicentre PMCF Study To Monitor The Safety And Performance Of Symani System In Microsurgical Reconstructive Procedures In A Real Life Setting - Studio Clinico multicentrico post-commercializzazione con lo scopo di monitorar

Title
Post-Market, Non- Randomized, Multicentre PMCF Study To Monitor The Safety And Performance Of Symani System In Microsurgical Reconstructive Procedures In A Real Life Setting - Studio Clinico multicentrico post-commercializzazione con lo scopo di monitorar
Code
PRIMO PMCF
Type
Sperimentale
Start Year
2022
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Description

Studio promosso da MMI Spa.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
14/09/2022 17:11